Specific Down-regulation of HER-2/neu Mediated by a Chimeric U6 Hammerhead Ribozyme Results in Growth Inhibition of Human Ovarian Carcinoma
Open Access
- 28 February 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (2) , 169-177
- https://doi.org/10.1006/mthe.2000.0241
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- High Cleavage Activity and Stability of Hammerhead Ribozymes with a Uniform 2′-Amino Pyrimidine ModificationBiochemical and Biophysical Research Communications, 1998
- Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.Proceedings of the National Academy of Sciences, 1995
- c-erbB-2/neu Oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasmsOtolaryngology -- Head and Neck Surgery, 1995
- Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotidesGene, 1994
- Reduction of erbB2 Gene-Product in Mamma Carcinoma Cell Lines by erbB2 mRNA-Specific and Tyrosine Kinase Consensus Phosphorothioate Antisense OligonucleotidesBiochemical and Biophysical Research Communications, 1994
- Partial reversion of transformed phenotype of B104 cancer cells by antisense nucleic acidsCancer Letters, 1993
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- A small catalytic oligoribonucleotideNature, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.Molecular and Cellular Biology, 1986